Precigen, Inc. (PGEN:NASDAQ) closed at $6.39 on October 16, 2026, down 11.26% on the day. The stock trades 28.9% below its 52-week high of $8.98 and 110.0% above its 52-week low of $3.04. Over the past year, it gained 59.6%. Precigen, Inc. is part of the Miscellaneous sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -16.64% | -18.87% | +25.94% | +55.35% | +59.63% |
In 252 trading sessions since October 16, 2025, PGEN closed higher on 118 days (47%). Its best day was November 14, 2025 (+25.65%) and its worst was November 19, 2025 (-12.99%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 2 times.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Find more stocks like PGEN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.